Abstract A polymorphic CA dinucleotide repeat sequence has been identified within the promoter of the human α2(I) procollagen gene, located at 7q21.3-q22.1. Nine alleles have been identified in unrelated individuals and the observed heterozygosity for the polymorphism was 0.66. This marker may be useful in the prenatal diagnosis of inherited connective tissue diseases in which the COL1A2 gene is involved. Furthermore, it may potentially improve the usefulness of the COL1A2 genetic system as an anthropogenetic marker.
Introduction
The collagens are a large and diverse family of structural proteins, and type I collagen is one of the primary components of the extracellular matrix. Of the 19 known types of collagen, type I collagen is the most abundant and widely expressed collagen in vertebrates. The α1(I) and α2(I) chains of type I collagen are encoded by the COL1A1 and COL1A2 genes, respectively (Dalgleish, 1997) . COL1A2 is approximately 38 kb in length, consists of 52 exons (Dalgleish, 1997) , and has been localized to 7q21.3-q22.1 (Retief et al. 1985) . This article describes a CA repeat polymorphism located within the promoter region of the COL1A2 gene.
Ethical approval for this project was obtained from the Ethics Committee of the Faculty of Health Sciences, University of Cape Town.
Source and description
During the sequence analysis of the 5Ј region of the α2(I) procollagen gene (Akai et al. 1998 ), a novel dinucleotide repeat was observed at position Ϫ1,400. Polymerase chain reaction (PCR) primers were designed to amplify the region of interest. P]-dCTP, 2U Taq polymerase (Roche Molecular Biochemicals, previously known as Boehringer Mannheim, Germany), and Taq buffer. Amplification conditions consisted of an initial denaturation at 95°C for 5 min, followed by 35 cycles of 95°C for 30s, 60°C for 30 s, and 72°C for 45s. Final extension was at 72°C for 10 min. PCR products of approximately 200 bp were resolved on denaturing 6% polyacrylamide gels and visualized by autoradiography.
Polymorphism and allele frequency
A total of nine alleles was detected. The allele frequencies were estimated from 47 unrelated individuals, on 94 chromosomes (Table 1 ). The observed heterozygosity was 0.66 and the polymorphic information content (PIC) 0.807. Codominant segregation was demonstrated in three three-generation CEPH (Centre d'Etude du Polymorphisme Humain) families, namely, family numbers 1349, 1362 and 1377.
Several polymorphisms in COL1A2 have been reported, few of which have been characterized in detail. In addition to silent base substitutions in the coding region of the gene (Dalgleish 1997) , restriction fragment length polymorphisms (RFLPs) (Mottes et al. 1989; Pepe et al. 1994 Pepe et al. , 1995 , a 38-bp length variant (Watson and Dalgleish 1990) , a variable nucleotide of tandem repeats (VNTR; Pepe 1993), and a GT dinucleotide repeat (Chi et al. 1992 ) have been described. The microsatellite described by Chi et al. (1992) consists of at least 20 repeats and is located in the first intron, at position ϩ1400. No recombination was observed between the promoter polymorphism described here, and the first intron polymorphism in the three CEPH families mentioned above.
Defects in either COL1A1 or COL1A2 cause dominant osteogenesis imperfecta (OI) or Ehlers-Danlos syndrome (EDS) types VIIA and VIIB. Multiple amino acid substitutions resulting in OI, as well as exon skipping mutations giving rise to OI or EDS, have been documented (Dalgleish 1997) . Prenatal diagnoses of these genetic disorders relies on identifying the COL1 gene that is affected. This is achieved by excluding the unaffected gene, and determining the haplotype associated with the disorder. In most instances, both these requirements are achieved using polymorphic markers (Pepe et al. 1994) , including the VNTR in intron 12 (Pepe 1993 ) and the dinucleotide repeat in intron 1 (Chi et al. 1992 ).
Polymorphisms of the two genes encoding the type I collagen peptides have proved to be valuable anthropogenetic markers (Pepe et al. 1995) . The polymorphism described here will improve the usefulness of the COL1A2 genetic system as an anthropogenetic marker, enabling the reconstruction of genetic relationships among different human populations. In addition, the identification of a highly polymorphic marker in this region will improve prenatal diagnosis of disorders such as OI and EDS. 
